Handelsavisen
prelaunch
Companies Healthcare 3705.TW
37
3705.TW TWSE Pharmaceuticals

YungShin Global Holding Corp

$55,70
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
5,40 %
Op margin
15,8 %
ROE
10,8 %
Net margin
10,5 %
Debt / equity
0,14
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

YungShin Global Holding Corp is a pharmaceutical company that develops and commercializes biopharmaceutical products, primarily in the areas of oncology and infectious diseases.

Business. YungShin Global Holding Corp (3705.TW) is a pharmaceutical company engaged in the development and sale of pharmaceutical products. The firm is headquartered in Taiwan and is primarily listed on the Taiwan Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %
SectorHealthcare
Business sectorPharmaceuticals & Medical Research
IndustryPharmaceuticals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
10,8 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 3705.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 3705.TW. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    YungShin Global Holding Corp (3705.TW) is a pharmaceutical company engaged in the development and sale of pharmaceutical products. The firm is headquartered in Taiwan and is primarily listed on the Taiwan Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorHealthcare
    Business sectorPharmaceuticals & Medical Research
    IndustryPharmaceuticals
    AI synthesis
    GENERATED

    YungShin Global Holding Corp maintains a strong capital structure with a debt-to-equity ratio of 0.14, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized by a current ratio of 3.47, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's free cash flow is negative at -129.82 million TWD, which may signal pressure on its ability to fund operations or growth without external financing.

    In terms of profitability, YungShin's return on equity (ROE) is 10.8%, and its return on assets (ROA) is 6.98%, both of which are strong indicators of efficient use of equity and assets to generate profit. These figures suggest the company is performing well relative to industry norms, although specific comparisons to cohort medians are not available in the provided data.

    The company's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. Geographically, the company's exposure is not explicitly detailed, but the absence of segmental or geographic diversification may represent a concentration risk.

    YungShin's growth trajectory is not explicitly outlined in the provided data, but the company's operating income of 1.32 billion TWD and net income of 880.82 million TWD suggest a stable financial performance. The company's capital expenditure of -508.41 million TWD indicates a net outflow, which may be related to investments in new facilities or equipment.

    The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests potential liquidity constraints, although the company's strong equity position may mitigate this risk. No specific dilution sources are identified in the available data, and the dilution risk is assessed as low.

    Recent events and filings are not detailed in the provided data, but the company's ESG scores indicate a strong governance profile with a score of 72.29 and a high ESG controversies score of 100.00, suggesting minimal involvement in ESG-related controversies.

    Key takeaways
    • YungShin Global Holding Corp has a strong equity position and a low debt-to-equity ratio, indicating a conservative capital structure.
    • The company's ROE and ROA are strong, suggesting efficient use of equity and assets to generate profit.
    • The company's free cash flow is negative, which may signal pressure on its ability to fund operations or growth without external financing.
    • The company's liquidity position is strong, as indicated by a current ratio of 3.47.
    • The company's ESG governance score is high, and it has a low ESG controversies score, indicating a strong ESG profile.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $55,70
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $8.16B
    Net cash
    -$951.8M
    Current ratio
    3.5
    Debt / equity
    0.1
    ROA
    7.0%
    ROE
    10.8%
    Cash conversion
    172.0%
    CapEx / revenue
    -6.1%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin15,8 %Above P75
    Net Margin10,5 %Above median
    ROE10,8 %Above median
    Capex / Rev-6,1 %Below median
    D/E0,14Above median
    Cash Conv1,72Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • YungShin Global Holding Corp Market data — financials · 2026-05-26
    • YungShin Global Holding Corp Market data — ESG · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    3705.TWCanonical
    TWSE · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage